Korio, Inc.-preview

Korioclinical

Korio, Inc.

Private

Doylestown, PennsylvaniaHealthcare & Life Scienceshttps://www.korioclinical.com/

Last Round

Series A

Sep 10, 2024

Est. Valuation

$17M

Total Funding Raised

$12.3M

Momentum Score

25 /100

Company Overview

Korio, Inc. is a healthtech company that provides a technology-first Randomization & Trial Supply Management (RTSM) platform for clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Pharma Supply Chain, Vertical SaaS, Compliance, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

RTSM platformRandomization and Trial Supply ManagementRTSMclinical trial softwareInteractive Response TechnologyIRTtrial supply managementpatient randomizationeClinical softwaremid-study migrationstudy rescueclinical supply chainCRO softwareGxP complianceclinical supply consulting

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Korio, Inc. Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Korio, Inc. Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Sep 10, 2024
Seed	Oct 10, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Chuck Harris

Founder, COO

Founding Team

Ryan Keane

Founder, CEO

Founding Team

Korio, Inc. Investors

Notable investors and investment history

Investor	Rounds
BIP Ventures	Series A
Boston Millennia Partners	Series A, Seed
Excelerate Health Ventures	Series A, Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 8, 2025
Jonathan Andrus joins the Board of Directors.

View all signals

Korio, Inc. Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Korio, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Korio, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersDoylestown, Pennsylvania

Employee Range32

Year Founded2021

Last FundingSep 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.